Ampersand Capital Partners has acquired Purna Pharmaceuticals. Purna Pharmaceuticals is a Belgian provider of development and manufacturing services. It specializes in liquid and semi-solid medicinal forms. These services are intended for the pharmaceutical sector. Ampersand Capital Partners is a private equity firm focused on healthcare and life sciences. It has assets worth $3 billion. The company was founded in 1988 and has headquarters in Boston, Amsterdam and London. It supports the growth of pharmaceutical services companies.[1][2][3]